Literature DB >> 2739055

Association of mitral valve prolapse and systemic abnormalities of connective tissue. A phenotypic continuum.

M J Glesby1, R E Pyeritz.   

Abstract

More than half of all patients evaluated in our clinic for the possible diagnosis of a heritable disorder of connective tissue could not be classified in the current nosology, yet they had considerable clinical evidence of a systemic defect of the extracellular matrix. As a group, these patients share many manifestations of the Marfan syndrome including long limbs, deformity of the thoracic cage, striae atrophicae, mitral valve prolapse, and mild dilatation of the aortic root. Clinical clustering did not emerge when patients were stratified by mitral valve prolapse or aortic dilatation. The clinical phenotype of patients with mitral valve prolapse constitutes a continuum, from Marfan syndrome at one extreme to isolated mitral valve prolapse due to myxomatous proliferation of the valve leaflets. In the absence of biochemical or DNA markers, discerning whether a patient with mitral valve prolapse and mild aortic root dilatation (in the absence of ectopia lentis or a family history) has Marfan syndrome, or another heritable disorder of connective tissue, will continue to be a clinical challenge. Until subclassification based on refined clinical, genetic, and laboratory investigations is possible, the patients we describe are best seen as having an "overlap" heritable connective-tissue disorder. We suggest the acronym "MASS phenotype" to emphasize involvement of the mitral valve, aorta, skeleton, and skin.

Entities:  

Mesh:

Year:  1989        PMID: 2739055

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  33 in total

1.  Toward an understanding of the cause of mitral valve prolapse.

Authors:  J A Towbin
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

2.  A locus for autosomal dominant mitral valve prolapse on chromosome 11p15.4.

Authors:  Lisa A Freed; James S Acierno; Daisy Dai; Maire Leyne; Jane E Marshall; Francesca Nesta; Robert A Levine; Susan A Slaugenhaupt
Journal:  Am J Hum Genet       Date:  2003-04-21       Impact factor: 11.025

3.  L-thyroxine therapy for congenital hypothyroidism and Marfan syndrome.

Authors:  R Khanna; S Dixit
Journal:  Indian J Pediatr       Date:  1992 May-Jun       Impact factor: 1.967

Review 4.  Mitral valve disease--morphology and mechanisms.

Authors:  Robert A Levine; Albert A Hagége; Daniel P Judge; Muralidhar Padala; Jacob P Dal-Bianco; Elena Aikawa; Jonathan Beaudoin; Joyce Bischoff; Nabila Bouatia-Naji; Patrick Bruneval; Jonathan T Butcher; Alain Carpentier; Miguel Chaput; Adrian H Chester; Catherine Clusel; Francesca N Delling; Harry C Dietz; Christian Dina; Ronen Durst; Leticia Fernandez-Friera; Mark D Handschumacher; Morten O Jensen; Xavier P Jeunemaitre; Hervé Le Marec; Thierry Le Tourneau; Roger R Markwald; Jean Mérot; Emmanuel Messas; David P Milan; Tui Neri; Russell A Norris; David Peal; Maelle Perrocheau; Vincent Probst; Michael Pucéat; Nadia Rosenthal; Jorge Solis; Jean-Jacques Schott; Ehud Schwammenthal; Susan A Slaugenhaupt; Jae-Kwan Song; Magdi H Yacoub
Journal:  Nat Rev Cardiol       Date:  2015-10-20       Impact factor: 32.419

Review 5.  Marfan's syndrome.

Authors:  Daniel P Judge; Harry C Dietz
Journal:  Lancet       Date:  2005-12-03       Impact factor: 79.321

6.  Understanding Marfan's syndrome.

Authors:  J R Gray; A B Bridges; M Boxer
Journal:  BMJ       Date:  1992-01-25

7.  Prevalence data on all Ghent features in a cross-sectional study of 87 adults with proven Marfan syndrome.

Authors:  Svend Rand-Hendriksen; Rigmor Lundby; Lena Tjeldhorn; Kai Andersen; Jon Offstad; Svein Ove Semb; Hans-Jørgen Smith; Benedicte Paus; Odd Geiran
Journal:  Eur J Hum Genet       Date:  2009-03-18       Impact factor: 4.246

8.  Temporal and spatial expression of collagens during murine atrioventricular heart valve development and maintenance.

Authors:  Jacqueline D Peacock; Yinhui Lu; Manuel Koch; Karl E Kadler; Joy Lincoln
Journal:  Dev Dyn       Date:  2008-10       Impact factor: 3.780

9.  FBN1 mutations in patients with descending thoracic aortic dissections.

Authors:  Ariel Brautbar; Scott A LeMaire; Luis M Franco; Joseph S Coselli; Dianna M Milewicz; John W Belmont
Journal:  Am J Med Genet A       Date:  2010-02       Impact factor: 2.802

10.  Systemic connective tissue features in women with fibromuscular dysplasia.

Authors:  Sarah O'Connor; Esther Sh Kim; Ellen Brinza; Rocio Moran; Natalia Fendrikova-Mahlay; Kathy Wolski; Heather L Gornik
Journal:  Vasc Med       Date:  2015-07-08       Impact factor: 3.239

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.